HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic hypothermia for cardiovascular collapse and severe respiratory distress after amniotic fluid embolism.

Abstract
Amniotic fluid embolism (AFE) is one of the most catastrophic complications that can occur during pregnancy or in the immediate postpartum period, frequently complicated by profound shock and cardiovascular collapse as well as severe respiratory distress. Therapeutic hypothermia (TH) is now commonly used to improve neurological outcomes after various types of hypoxic injury and is widely used in the treatment of postanoxic injury after cardiac arrest (CA). To our knowledge, no studies have evaluated whether TH could be effectively used in AFE, and its use for this indication has not been described previously. We describe the case of a 32-year-old woman, who developed clinical manifestations of AFE and suffered a CA in the 29th week of her pregnancy. She received prolonged CPR (40 minutes until ROSC) and remained comatose. TH was induced and maintained for a total of 60 hours using an endovascular device, followed by controlled rewarming and maintenance of strict normothermia. The patient survived and was neurologically intact (CPC 1) at 6 months of follow up.
AuthorsCynthia Ocegueda-Pacheco, J Carlos García, Joseph Varon, Kees H Polderman
JournalTherapeutic hypothermia and temperature management (Ther Hypothermia Temp Manag) Vol. 4 Issue 2 Pg. 96-8 (Jun 2014) ISSN: 2153-7933 [Electronic] United States
PMID24670228 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Embolism, Amniotic Fluid (therapy)
  • Female
  • Fetal Death
  • Heart Arrest (therapy)
  • Humans
  • Hypothermia, Induced (methods)
  • Obstetric Labor, Premature
  • Pregnancy
  • Respiratory Distress Syndrome (therapy)
  • Shock (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: